Literature DB >> 18666312

Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis.

Yoshio Yamaoka.   

Abstract

Interactions between BabA and Lewis b (Le(b)) related antigens are the best characterized adhesin-receptor interactions in Helicobacter pylori (H pylori). Several mechanisms for the regulation of BabA expression are predicted, including at both transcriptional and translational levels. The formation of chimeric proteins (babA/B or babB/A chimeras) seems to play an especially important role in translational regulation. Chimeric BabB/A protein had the potential to bind Le(b); however, protein production was subject to phase variation through slipped strand mispairing. The babA gene was cloned initially from strain CCUG17875, which contains a silent babA1 gene and an expressed babA2 gene. The sequence of these two genes differs only by the presence of a 10 bp deletion in the signal peptide sequence of babA1 that eliminates its translational initiation codon. However, the babA1 type deletion was found only in strain CCUG17875. A few studies evaluated BabA status by immunoblot and confirmed that BabA-positive status in Western strains was closely associated with severe clinical outcomes. BabA-positive status also was associated with the presence of other virulence factors (e.g. cagA-positive status and vacA s1 genotype). A small class of strains produced low levels of the BabA protein and lacked Le(b) binding activity. These were more likely to be associated with increased mucosal inflammation and severe clinical outcomes than BabA-positive strains that exhibited Le(b) binding activity. The underlying mechanism is unclear, and further studies will be necessary to investigate how the complex BabA-receptor network is functionally coordinated during the interaction of H pylori with the gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18666312      PMCID: PMC2731175          DOI: 10.3748/wjg.14.4265

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  55 in total

1.  Differences in genotypes of Helicobacter pylori from different human populations.

Authors:  D Kersulyte; A K Mukhopadhyay; B Velapatiño; W Su; Z Pan; C Garcia; V Hernandez; Y Valdez; R S Mistry; R H Gilman; Y Yuan; H Gao; T Alarcón; M López-Brea; G Balakrish Nair; A Chowdhury; S Datta; M Shirai; T Nakazawa; R Ally; I Segal; B C Wong; S K Lam; F O Olfat; T Borén; L Engstrand; O Torres; R Schneider; J E Thomas; S Czinn; D E Berg
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

2.  Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families.

Authors:  R A Alm; J Bina; B M Andrews; P Doig; R E Hancock; T J Trust
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin.

Authors:  M Gerhard; N Lehn; N Neumayer; T Borén; R Rad; W Schepp; S Miehlke; M Classen; C Prinz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques.

Authors:  Jay V Solnick; Lori M Hansen; Nina R Salama; Jenni K Boonjakuakul; Michael Syvanen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-03       Impact factor: 11.205

5.  Analysis of the vacA, cagA, cagE, iceA, and babA2 genes in Helicobacter pylori from sixty-one pediatric patients from the Midwestern United States.

Authors:  Raymond P Podzorski; Diane S Podzorski; Ann Wuerth; Vasundhara Tolia
Journal:  Diagn Microbiol Infect Dis       Date:  2003-06       Impact factor: 2.803

6.  Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.

Authors:  R A Alm; L S Ling; D T Moir; B L King; E D Brown; P C Doig; D R Smith; B Noonan; B C Guild; B L deJonge; G Carmel; P J Tummino; A Caruso; M Uria-Nickelsen; D M Mills; C Ives; R Gibson; D Merberg; S D Mills; Q Jiang; D E Taylor; G F Vovis; T J Trust
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

7.  Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Philippe Lehours; Armelle Ménard; Sandrine Dupouy; Bernard Bergey; Fréderique Richy; Frank Zerbib; Agnès Ruskoné-Fourmestraux; Jean Charles Delchier; Francis Mégraud
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

8.  The MUC5AC glycoprotein is the primary receptor for Helicobacter pylori in the human stomach.

Authors:  Jeroen H B Van de Bovenkamp; Jafar Mahdavi; Anita M Korteland-Van Male; Hans A Büller; Alexandra W C Einerhand; Thomas Borén; Jan Dekker
Journal:  Helicobacter       Date:  2003       Impact factor: 5.753

9.  Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection.

Authors:  B-S Sheu; S-M Sheu; H-B Yang; A-H Huang; J-J Wu
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

10.  babA2- and cagA-positive Helicobacter pylori strains are associated with duodenal ulcer and gastric carcinoma in Brazil.

Authors:  Adriana Gonçalves Oliveira; Adriana Santos; Juliana Becattini Guerra; Gifone Aguiar Rocha; Andreia Maria Camargos Rocha; Celso Affonso Oliveira; Mônica Maria Demas Alvares Cabral; Ana Margarida Miguel Ferreira Nogueira; Dulciene Maria Magalhães Queiroz
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  38 in total

Review 1.  Association of Helicobacter pylori babA2 with peptic ulcer disease and gastric cancer.

Authors:  Mo-Ye Chen; Cai-Yun He; Xue Meng; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

2.  Helicobacter pylori bab genes during chronic colonization.

Authors:  Mario J Matteo; Rita I Armitano; Mariela Romeo; Andres Wonaga; Martín Olmos; Mariana Catalano
Journal:  Int J Mol Epidemiol Genet       Date:  2011-07-23

Review 3.  Helicobacter pylori virulence genes and host genetic polymorphisms as risk factors for peptic ulcer disease.

Authors:  Muhammad Miftahussurur; Yoshio Yamaoka
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-10-16       Impact factor: 3.869

4.  The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone.

Authors:  Sung Woo Jung; Mitsushige Sugimoto; Seiji Shiota; David Y Graham; Yoshio Yamaoka
Journal:  Infect Immun       Date:  2011-10-28       Impact factor: 3.441

Review 5.  Mechanisms of disease: Helicobacter pylori virulence factors.

Authors:  Yoshio Yamaoka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-12       Impact factor: 46.802

6.  The cag PAI is intact and functional but HP0521 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore.

Authors:  H-M A Schmidt; S Andres; C Nilsson; Z Kovach; N O Kaakoush; L Engstrand; K-L Goh; K M Fock; D Forman; H Mitchell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-16       Impact factor: 3.267

Review 7.  The significance of virulence factors in Helicobacter pylori.

Authors:  Seiji Shiota; Rumiko Suzuki; Yoshio Yamaoka
Journal:  J Dig Dis       Date:  2013-07       Impact factor: 2.325

8.  Systematic review and meta-analysis: the relationship between the Helicobacter pylori dupA gene and clinical outcomes.

Authors:  Seiji Shiota; Osamu Matsunari; Masahide Watada; Katsuhiro Hanada; Yoshio Yamaoka
Journal:  Gut Pathog       Date:  2010-10-31       Impact factor: 4.181

9.  Assessment of cagE and babA mRNA expression during morphological conversion of Helicobacter pylori from spiral to coccoid.

Authors:  Farkhondeh Poursina; Jamshid Faghri; Sharareh Moghim; Hamid Zarkesh-Esfahani; Bahram Nasr-Esfahani; Hossein Fazeli; Akbar Hasanzadeh; Hajieh Ghasemian Safaei
Journal:  Curr Microbiol       Date:  2012-12-24       Impact factor: 2.188

Review 10.  Effect of bacterial and host factors on Helicobacter pylori eradication therapy.

Authors:  Takahiro Uotani; Muhammad Miftahussurur; Yoshio Yamaoka
Journal:  Expert Opin Ther Targets       Date:  2015-08-06       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.